Formatech, Inc. to Donate Services to Formulate and Fill Femta Pharmaceuticals’ FM101 Monoclonal Antibody under Its "Fillanthropy(TM) Program"
7/30/2010 11:26:28 AM
More...
|
Formatech, Inc. Donates Manufacturing Services to RegeneRx Biopharmaceuticals, Inc. (RGRX) to Produce Experimental Drug for the Treatment of Multiple Sclerosis
4/30/2010 9:08:03 AM
More...
|
Cellceutix Signs Agreement for Kevetrin(TM) Formulation With Formatech, Inc.
3/22/2010 11:05:32 AM
More...
|
Formatech, Inc. Donates Services to Formulate and Fill TRACON Pharmaceuticals, Inc.'s TRC102 Compound under Its "Fillanthropy(TM) Program"
3/22/2010 9:16:32 AM
More...
|
USPTO Grants Formatech Novel Drug Formulation Patent
2/12/2010 9:39:11 AM
More...
|
Formatech, Inc. Donates over $300K in Manufacturing Services Through "Fillanthropy Program"
1/29/2010 9:53:54 AM
More...
|
Formatech, Inc. Donates over $300K in Manufactuing Services Through "Fillanthropy Program"
1/28/2010 9:13:25 AM
More...
|
Formatech, Inc.'s "Fillanthropy Program" Donates Services to Formulate and Fill ViroMed's VM206 Vaccine Targeting Breast Cancer
1/5/2010 9:40:51 AM
More...
|
Formatech, Inc. Release: The New Face of Formatech.com
11/20/2009 8:34:28 AM
More...
|
Formatech, Inc. to Donate Services to Manufacture KAI Pharmaceuticals, Inc.'s Clinical Candidate Under Its "Fillanthropy(TM) Program"
11/18/2009 9:35:04 AM
More...
|
|